Quick Answer
ADIAL PHARMACEUTICALS, INC. reported Shares Outstanding of 1.11 million shares for fiscal year 2025.
ADIAL PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.11M | +329.2% |
| 2024 | 258,826 | -84.4% |
| 2023 | 1.66M | +55.8% |
| 2022 | 1.07M | -94.9% |
| 2021 | 20.95M | +45.5% |
| 2020 | 14.39M | +38.8% |
| 2019 | 10.37M | +51.1% |
| 2018 | 6.86M | +110.0% |
| 2017 | 3.27M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 23.84M | +272.1% | +10.7% |
| June 30, 2025 | 21.53M | +401.5% | +223.9% |
| March 31, 2025 | 6.65M | +64.0% | +2.7% |
| December 31, 2024 | 6.47M | +289.2% | +1.1% |
| September 30, 2024 | 6.41M | +425.9% | +49.2% |
| June 30, 2024 | 4.29M | +258.5% | +5.9% |
| March 31, 2024 | 4.05M | -85.8% | +143.8% |
| December 31, 2023 | 1.66M | +55.8% | +36.6% |
- ADIAL PHARMACEUTICALS, INC. showed an increase of +329.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, ADIAL PHARMACEUTICALS, INC.’s shares outstanding has declined by 66.0% (from 3.27 million shares to 1.11 million shares).
- The most recent figure is from ADIAL PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: